Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LAURUS LABS ASTRAZENECA PHARMA LAURUS LABS /
ASTRAZENECA PHARMA
 
P/E (TTM) x 105.5 95.5 110.5% View Chart
P/BV x 5.2 22.7 23.1% View Chart
Dividend Yield % 0.5 0.3 169.8%  

Financials

 LAURUS LABS    ASTRAZENECA PHARMA
EQUITY SHARE DATA
    LAURUS LABS
Mar-23
ASTRAZENECA PHARMA
Mar-23
LAURUS LABS /
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs6263,620 17.3%   
Low Rs2872,438 11.8%   
Sales per share (Unadj.) Rs112.1401.2 28.0%  
Earnings per share (Unadj.) Rs14.839.7 37.2%  
Cash flow per share (Unadj.) Rs20.846.2 45.0%  
Dividends per share (Unadj.) Rs2.0016.00 12.5%  
Avg Dividend yield %0.40.5 83.0%  
Book value per share (Unadj.) Rs74.7234.4 31.9%  
Shares outstanding (eoy) m538.6525.00 2,154.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.17.5 53.9%   
Avg P/E ratio x30.976.3 40.5%  
P/CF ratio (eoy) x21.965.5 33.5%  
Price / Book Value ratio x6.112.9 47.3%  
Dividend payout %13.540.3 33.6%   
Avg Mkt Cap Rs m245,84075,718 324.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,5742,591 215.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m60,40610,030 602.3%  
Other income Rs m60261 23.0%   
Total revenues Rs m60,46610,291 587.6%   
Gross profit Rs m15,9221,249 1,274.9%  
Depreciation Rs m3,241163 1,993.1%   
Interest Rs m1,6526 26,217.5%   
Profit before tax Rs m11,0891,341 827.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,123348 897.2%   
Profit after tax Rs m7,966993 802.3%  
Gross profit margin %26.412.5 211.7%  
Effective tax rate %28.226.0 108.5%   
Net profit margin %13.29.9 133.2%  
BALANCE SHEET DATA
Current assets Rs m34,6179,359 369.9%   
Current liabilities Rs m24,3234,844 502.1%   
Net working cap to sales %17.045.0 37.9%  
Current ratio x1.41.9 73.7%  
Inventory Days Days1449 29.2%  
Debtors Days Days1039 24.4%  
Net fixed assets Rs m41,9872,061 2,036.8%   
Share capital Rs m1,07750 2,154.6%   
"Free" reserves Rs m39,1775,811 674.2%   
Net worth Rs m40,2555,861 686.8%   
Long term debt Rs m7,6140-   
Total assets Rs m76,60411,421 670.7%  
Interest coverage x7.7213.9 3.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.9 89.8%   
Return on assets %12.68.7 143.5%  
Return on equity %19.816.9 116.8%  
Return on capital %26.623.0 115.8%  
Exports to sales %00-   
Imports to sales %22.737.4 60.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m13,7203,747 366.2%   
Fx inflow Rs m43,470612 7,102.9%   
Fx outflow Rs m13,7203,747 366.2%   
Net fx Rs m29,750-3,135 -949.0%   
CASH FLOW
From Operations Rs m9,939583 1,705.1%  
From Investments Rs m-9,961181 -5,500.1%  
From Financial Activity Rs m-266-245 108.8%  
Net Cashflow Rs m-297519 -57.2%  

Share Holding

Indian Promoters % 27.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 36.5 5.4 673.8%  
FIIs % 25.4 2.7 954.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.8 25.0 291.2%  
Shareholders   382,880 29,032 1,318.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LAURUS LABS With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LAURUS LABS vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LAURUS LABS vs ASTRAZENECA PHARMA Share Price Performance

Period LAURUS LABS ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -0.11% 0.01% 1.18%
1-Month -3.28% -3.61% -0.75%
1-Year 35.25% 59.20% 61.82%
3-Year CAGR 2.83% 20.50% 18.16%
5-Year CAGR 37.19% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the LAURUS LABS share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of LAURUS LABS hold a 27.2% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LAURUS LABS and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, LAURUS LABS paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 13.5%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of LAURUS LABS , and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.